The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
High-Throughput Screening: today’s biochemical and cell-based approaches
Abstract
High-throughput screening (HTS) provides starting chemical matter in the adventure of developing a new drug. In this review, we survey several HTS methods used today for hit identification, organized in two main flavors: biochemical and cell-based assays. Biochemical assays discussed include fluorescence polarization and anisotropy, FRET, TR-FRET, and fluorescence lifetime analysis. Binding-based methods are also surveyed, including NMR, SPR, mass spectrometry, and DSF. On the other hand, cell-based assays discussed include viability, reporter gene, second messenger, and high-throughput microscopy assays. We devote some emphasis to high-content screening, which is becoming very popular. An advisable stage after hit discovery using phenotypic screens is target deconvolution, and we provide an overview of current chemical proteomics, in silico, and chemical genetics tools. Emphasis is made on recent CRISPR/dCas-based screens. Lastly, we illustrate some of the considerations that inform the choice of HTS methods and point to some areas with potential interest for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1951 · Cited by 2,620
Niesen, F. H., Berglund, H., & Vedadi, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.321 · Cited by 2,408
Fluorescence Lifetime Measurements and Biological Imaging
Berezin, M. Y., & Achilefu, S. (2010) · Chemical Reviews · doi:10.1021/cr900343z · Cited by 2,403
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
CellProfiler 3.0: Next-generation image processing for biology
McQuin, C., Goodman, A., Chernyshev, V., Kamentsky, L., Cimini, B. A., Karhohs, K. W., Doan, M., Ding, L., Rafelski, S. M., Thirstrup, D., et al. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2005970 · Cited by 1,825
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
A Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence Imaging
Tanenbaum, M. E., Gilbert, L. A., Qi, L. S., Weissman, J. S., & Vale, R. D. (2014) · Cell · doi:10.1016/j.cell.2014.09.039 · Cited by 1,580
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Correlating chemical sensitivity and basal gene expression reveals mechanism of action
Rees, M. G., Seashore-Ludlow, B., Cheah, J. H., Adams, D. J., Price, E. V., Gill, S., Javaid, S., Coletti, M. E., Jones, V. L., Bodycombe, N. E., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1986 · Cited by 898
Fluorescent protein FRET: the good, the bad and the ugly
Piston, D. W., & Kremers, G.-J. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.08.003 · Cited by 849
Statistical practice in high-throughput screening data analysis
Malo, N., Hanley, J. A., Cerquozzi, S., Pelletier, J., & Nadon, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1186 · Cited by 721
Multidimensional Drug Profiling By Automated Microscopy
Perlman, Z. E., Slack, M. D., Feng, Y., Mitchison, T. J., Wu, L. F., & Altschuler, S. J. (2004) · Science · doi:10.1126/science.1100709 · Cited by 660
High-throughput screening assays for the identification of chemical probes
Inglese, J., Johnson, R. L., Simeonov, A., Xia, M., Zheng, W., Austin, C. P., & Auld, D. S. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.17 · Cited by 614
Cell Proliferation and Cytotoxicity Assays
Adan, A., Kiraz, Y., & Baran, Y. (2016) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201017666160808160513 · Cited by 584
Target profiling of small molecules by chemical proteomics
Rix, U., & Superti-Furga, G. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.216 · Cited by 575
The discovery of first-in-class drugs: origins and evolution
Eder, J., Sedrani, R., & Wiesmann, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4336 · Cited by 514
Degorce, F. (2009) · Current Chemical Genomics · doi:10.2174/1875397300903010022 · Cited by 501
Phenotypic screens as a renewed approach for drug discovery
Zheng, W., Thorne, N., & McKew, J. C. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.001 · Cited by 423
In Vitro Cytotoxicity and Cell Viability Assays: Principles, Advantages, and Disadvantages
Aslantürk, Ö. S. (2018) · Genotoxicity - A Predictable Risk to Our Actual World · doi:10.5772/intechopen.71923 · Cited by 408
High content screening: seeing is believing
Zanella, F., Lorens, J. B., & Link, W. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.02.005 · Cited by 391
Chemical proteomics approaches for identifying the cellular targets of natural products
Wright, M. H., & Sieber, S. A. (2016) · Natural Product Reports · doi:10.1039/c6np00001k · Cited by 391
Tethering: Fragment-Based Drug Discovery
Erlanson, D. A., Wells, J. A., & Braisted, A. C. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140409 · Cited by 385
Discovering potent and selective reversible inhibitors of enzymes in complex proteomes
Leung, D., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2003) · Nature Biotechnology · doi:10.1038/nbt826 · Cited by 385
Fluorescence polarization assays in small molecule screening
Lea, W. A., & Simeonov, A. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.537322 · Cited by 379
Drug Affinity Responsive Target Stability (DARTS) for Small-Molecule Target Identification
Pai, M. Y., Lomenick, B., Hwang, H., Schiestl, R., McBride, W., Loo, J. A., & Huang, J. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2269-7_22 · Cited by 354
Zhang, R., & Xie, X. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.173 · Cited by 317
Confocal microscopy of colloids
Prasad, V, Semwogerere, D., & Weeks, E. R. (2007) · Journal of Physics: Condensed Matter · doi:10.1088/0953-8984/19/11/113102 · Cited by 310
High‐throughput screening and small animal models, where are we?
Giacomotto, J., & Ségalat, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00725.x · Cited by 293
Ursu, O., Rayan, A., Goldblum, A., & Oprea, T. I. (2011) · WIREs Computational Molecular Science · doi:10.1002/wcms.52 · Cited by 276
Microfluidics for cell-based high throughput screening platforms—A review
Du, G., Fang, Q., & den Toonder, J. M. J. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.11.023 · Cited by 276
The use of resonance energy transfer in high-throughput screening: BRET versus FRET
Boute, N., Jockers, R., & Issad, T. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02062-x · Cited by 269
Higher-throughput, label-free, real-time molecular interaction analysis
Rich, R. L., & Myszka, D. G. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2006.10.040 · Cited by 264
Sidrauski, C., Tsai, J. C., Kampmann, M., Hearn, B. R., Vedantham, P., Jaishankar, P., Sokabe, M., Mendez, A. S., Newton, B. W., Tang, E. L., et al. (2015) · eLife · doi:10.7554/elife.07314 · Cited by 256
Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes
Hofstadler, S. A., & Sannes-Lowery, K. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2083 · Cited by 250
Jost, M., Chen, Y., Gilbert, L. A., Horlbeck, M. A., Krenning, L., Menchon, G., Rai, A., Cho, M. Y., Stern, J. J., Prota, A. E., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.012 · Cited by 247
McKim Jr., J. (2010) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620710790596736 · Cited by 231
Split Green Fluorescent Proteins: Scope, Limitations, and Outlook
Romei, M. G., & Boxer, S. G. (2019) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-051013-022846 · Cited by 229
Affinity selection-mass spectrometry screening techniques for small molecule drug discovery
Annis, D. A., Nickbarg, E., Yang, X., Ziebell, M. R., & Whitehurst, C. E. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.07.011 · Cited by 224
Cell-Based Assays for High-Throughput Screening
An, W. F., & Tolliday, N. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9251-z · Cited by 220
Chimeric G Proteins Allow a High-Throughput Signaling Assay of Gi-Coupled Receptors
Coward, P., Chan, S. D. H., Wada, H. G., Humphries, G. M., & Conklin, B. R. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4061 · Cited by 215
Gel-Based and Gel-Free Quantitative Proteomics Approaches at a Glance
Abdallah, C., Dumas-Gaudot, E., Renaut, J., & Sergeant, K. (2012) · International Journal of Plant Genomics · doi:10.1155/2012/494572 · Cited by 213
Nanoscale synthesis and affinity ranking
Gesmundo, N. J., Sauvagnat, B., Curran, P. J., Richards, M. P., Andrews, C. L., Dandliker, P. J., & Cernak, T. (2018) · Nature · doi:10.1038/s41586-018-0056-8 · Cited by 206
Cell-based assays: fuelling drug discovery
Michelini, E., Cevenini, L., Mezzanotte, L., Coppa, A., & Roda, A. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3933-z · Cited by 197
Six-Color Time-Resolved Förster Resonance Energy Transfer for Ultrasensitive Multiplexed Biosensing
Geißler, D., Stufler, S., Löhmannsröben, H.-G., & Hildebrandt, N. (2013) · Journal of the American Chemical Society · doi:10.1021/ja310317n · Cited by 191
NanoBRET: The Bright Future of Proximity-Based Assays
Dale, N. C., Johnstone, E. K. M., White, C. W., & Pfleger, K. D. G. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00056 · Cited by 182
A split fluorescent reporter with rapid and reversible complementation
Tebo, A. G., & Gautier, A. (2019) · Nature Communications · doi:10.1038/s41467-019-10855-0 · Cited by 177
Screening Technologies for Small Molecule Discovery: The State of the Art
Janzen, W. P. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.07.015 · Cited by 176
The beautiful cell: high-content screening in drug discovery
Bickle, M. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3788-3 · Cited by 176
Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects
Dalvit, C., & Vulpetti, A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01210 · Cited by 176
Characterizing heterogeneous cellular responses to perturbations
Slack, M. D., Martinez, E. D., Wu, L. F., & Altschuler, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807038105 · Cited by 162
Current perspectives in fragment-based lead discovery (FBLD)
Lamoree, B., & Hubbard, R. E. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170028 · Cited by 161
Target deconvolution techniques in modern phenotypic profiling
Lee, J., & Bogyo, M. S. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.12.022 · Cited by 159
Maddah, M., Heidmann, J. D., Mandegar, M. A., Walker, C. D., Bolouki, S., Conklin, B. R., & Loewke, K. E. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.007 · Cited by 148
Yasgar, A., Jadhav, A., Simeonov, A. M., & Coussens, N. P. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3673-1_5 · Cited by 146
Fluorescence‐ and bioluminescence‐based approaches to study GPCR ligand binding
Stoddart, L. A., White, C. W., Nguyen, K., Hill, S. J., & Pfleger, K. D. G. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13316 · Cited by 144
Microscopic imaging techniques for drug discovery
Bullen, A. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2446 · Cited by 140
A Comparison of ALPHAScreen, TR-FRET, and TRF as Assay Methods for FXR Nuclear Receptors
Glickman, J. F., Wu, X. Y., Mercuri, R., Illy, C., Bowen, B. R., He, Y., & Sills, M. A. (2002) · SLAS DISCOVERY · doi:10.1177/108705710200700102 · Cited by 133
Ligand–receptor interaction platforms and their applications for drug discovery
Ye, F. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.715631 · Cited by 130
Annis, D. A., Nazef, N., Chuang, C., Scott, M. P., & Nash, H. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja048365x · Cited by 130
Cellular platforms for HTS: three case studies
Johnston, P. A., & Johnston, P. A. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02140-7 · Cited by 130
Optical biosensors : today and tomorrow
Ligler, F. S., & Taitt, C. R. (2008) · doi:10.1016/b978-0-444-53125-4.x5001-3 · Cited by 128
Kampmann, M., Bassik, M. C., & Weissman, J. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307002110 · Cited by 123
Chemical Genetics–Based Target Identification in Drug Discovery
Cong, F., Cheung, A. K., & Huang, S.-M. A. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134639 · Cited by 120
Scintillation Proximity Assays in High-Throughput Screening
Glickman, J. F., Schmid, A., & Ferrand, S. (2008) · Assay and Drug Development Technologies · doi:10.1089/adt.2008.135 · Cited by 114
Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications
Bian, Y., & Xie, X.-Q. S. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0216-7 · Cited by 110
Chemical composition of DNA-encoded libraries, past present and future
Dickson, P., & Kodadek, T. J. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob00581a · Cited by 104
Chemical and semisynthetic approaches to study and target deubiquitinases
Gopinath, P., Ohayon, S., Nawatha, M., & Brik, A. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00083e · Cited by 101
Cell-Based Assay Design for High-Content Screening of Drug Candidates
Nierode, G. J., Kwon, P. S., Dordick, J. S., & Kwon, S. (2016) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1508.08007 · Cited by 97
Stahelin, R. V. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-10-0713 · Cited by 96
Fluorescence anisotropy (polarization): from drug screening to precision medicine
Zhang, H., Wu, Q., & Berezin, M. Y. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1075001 · Cited by 95
Recent developments in protein–ligand affinity mass spectrometry
Jonker, N., Kool, J., Irth, H., & Niessen, W. M. A. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4350-z · Cited by 95
Nakajima, Y., Kimura, T., Sugata, K., Enomoto, T., Asakawa, A., Kubota, H., Ikeda, M., & Ohmiya, Y. (2005) · BioTechniques · doi:10.2144/05386st03 · Cited by 93
CRISPR Approaches to Small Molecule Target Identification
Jost, M., & Weissman, J. S. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00965 · Cited by 88
Future challenges with DNA-encoded chemical libraries in the drug discovery domain
Zhao, G., Huang, Y., Zhou, Y., Li, Y., & Li, X. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1614559 · Cited by 87
Cell-Based Versus Isolated Target Screening: How Lucky Do You Feel?
Moore, K., & Rees, S. (2001) · SLAS DISCOVERY · doi:10.1177/108705710100600202 · Cited by 86
Bajorath, J. (2015) · F1000Research · doi:10.12688/f1000research.6653.1 · Cited by 84
Impedance-based cellular assay technologies: recent advances, future promise
McGuinness, R. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.08.004 · Cited by 83
Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches
Kubota, K., Funabashi, M., & Ogura, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.08.002 · Cited by 81
Design and Implementation of High-Throughput Screening Assays
Macarrón, R., & Hertzberg, R. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-258-2_1 · Cited by 79
Biochemical applications of mass spectrometry in pharmaceutical drug discovery
Geoghegan, K. F., & Kelly, M. A. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20019 · Cited by 78
Cell-based drug screening on microfluidics
Zhai, J., Yi, S., Jia, Y., Mak, P., & Martins, R. P. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.05.018 · Cited by 76
Functional genomics to uncover drug mechanism of action
Nijman, S. M. B. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1963 · Cited by 75
Fragment‐based Drug Discovery Lessons and Outlook
(2016) · Methods and principles in medicinal chemistry · doi:10.1002/9783527683604 · Cited by 70
The 3F Library: Fluorinated Fsp3‐Rich Fragments for Expeditious 19F NMR Based Screening
Troelsen, N. S., Shanina, E., González‐Romero, D., Danková, D., Jensen, I. S. A., Śniady‐Maciążek, K., Nami, F., Zhang, H., Rademacher, C., Cuenda, A., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201913125 · Cited by 65
CP-CHARM: segmentation-free image classification made accessible
Uhlmann, V., Singh, S., & Carpenter, A. E. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-0895-y · Cited by 64
Microfluidic Devices for Drug Assays
Regnault, C., Dheeman, D. S., & Hochstetter, A. (2018) · Microarrays · doi:10.3390/ht7020018 · Cited by 62
Quality control of cell-based high-throughput drug screening
Zhang, Z., Guan, N., Li, T., Mais, D. E., & Wang, M. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.03.006 · Cited by 60
Chan, J. N. Y., Vuckovic, D., Sleno, L., Olsen, J. B., Pogoutse, O., Havugimana, P. C., Hewel, J. A., Bajaj, N., Wang, Y., Musteata, F. M., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016642 · Cited by 58
High-Throughput Affinity-Based Technologies for Small-Molecule Drug Discovery
Zhu, Z., & Cuozzo, J. W. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109350114 · Cited by 58
A review of the analysis of complex time-resolved fluorescence anisotropy data
Smith, T. A., & Ghiggino, K. P. (2015) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/3/2/022001 · Cited by 57
Functional cell-based uHTS in chemical genomic drug discovery
Croston, G. E. (2002) · Trends in biotechnology · doi:10.1016/s0167-7799(02)01906-6 · Cited by 57
Application of Scintillation Proximity Assay in Drug Discovery
Wu, S., & Liu, B. (2005) · BioDrugs · doi:10.2165/00063030-200519060-00005 · Cited by 54
NMR-Fragment Based Virtual Screening: A Brief Overview
Singh, M., Tam, B., & Akabayov, B. (2018) · Molecules · doi:10.3390/molecules23020233 · Cited by 54
New Fluorescence Techniques for High-Throughput Drug Discovery
Jager, S., Brand, L., & Eggeling, C. (2003) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201033377382 · Cited by 53
Couturier, C., & Deprez, B. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00100 · Cited by 52
Three Essential Resources to Improve Differential Scanning Fluorimetry (DSF) ExperimentsPreprint
Wu, T., Yu, J., Gale-Day, Z. J., Woo, A. S., Suresh, A., Hornsby, M. J., & Gestwicki, J. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.22.002543 · Cited by 52
An overview of Ca2+mobilization assays in GPCR drug discovery
Ma, Q., Ye, L., Liu, H., Shi, Y., & Zhou, N. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1303473 · Cited by 50
Moree, B., Yin, G., Lázaro, D. F., Munari, F., Strohäker, T., Giller, K., Becker, S., Outeiro, T. F., Zweckstetter, M., & Salafsky, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.636027 · Cited by 49
Chemical genetics in drug discovery
Cacace, E., Kritikos, G., & Typas, A. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.05.020 · Cited by 46
Edwards, B. S., Kuckuck, F. W., & Sklar, L. A. (1999) · Cytometry · Cited by 45
Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments
Ohmuro‐Matsuyama, Y., Chung, C.-I., & Ueda, H. (2013) · BMC Biotechnology · doi:10.1186/1472-6750-13-31 · Cited by 43
Bergsdorf, C., & Ottl, J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.524641 · Cited by 43
Chaikuad, A., Lang, S., Brennan, P. E., Temperini, C., Fedorov, O., Hollander, J. G., Nachane, R., Abell, C., Müller, S., Siegal, G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01719 · Cited by 41
High-throughput flow cytometry for drug discovery: principles, applications, and case studies
Ding, M., Kaspersson, K., Murray, D., & Bardelle, C. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.09.005 · Cited by 38
Cao, J., Galbraith, E. K., Sun, T. S., et al. (2011) · Journal of Physics Conference Series · doi:10.1088/1742-6596/307/1/012050 · Cited by 37
Target Identification Strategies in Chemical Genetics
Tochtrop, G. P. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207043328391 · Cited by 32
A Liquid Chromatography/Mass Spectrometry Method for Screening Disulfide Tethering Fragments
Hallenbeck, K. K., Davies, J. L., Merron, C., Ogden, P., Sijbesma, E., Ottmann, C., Renslo, A. R., Wilson, C., & Arkin, M. R. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217732072 · Cited by 32
Self-citationPalchaudhuri, R., & Hergenrother, P. J. (2010) · ACS Chemical Biology · doi:10.1021/cb100310h · Cited by 31
Screening-based approaches to identify small molecules that inhibit protein–protein interactions
Choi, S., & Choi, K.-Y. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1280456 · Cited by 29
Elucidating drug targets and mechanisms of action by genetic screens in mammalian cells
Kampmann, M. (2017) · Chemical Communications · doi:10.1039/c7cc02349a · Cited by 29
Feyfant, E., Cross, J. B., Paris, K., et al. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-931-4_12 · Cited by 28
A Bead‐Based Proximity Assay for BRD4 Ligand Discovery
Roberts, J. M., & Bradner, J. E. (2015) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch150024 · Cited by 28
Lin, H., Fan, T., Sui, J. H., Wang, G., Chen, J., Zhuo, S., & Zhang, H. (2019) · Nanoscale · doi:10.1039/c9nr04902a · Cited by 28
The 3F Library: Fluorinated Fsp3‐Rich Fragments for Expeditious 19F NMR Based Screening
Troelsen, N. S., Shanina, E., González‐Romero, D., Danková, D., Jensen, I. S. A., Śniady, K. J., Nami, F., Zhang, H., Rademacher, C., Cuenda, A., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201913125 · Cited by 26
Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective
Ding, M., Clark, R., Bardelle, C., Backmark, A., Norris, T., Williams, W., Wigglesworth, M. J., & Howes, R. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218775074 · Cited by 18
Imaduwage, K. P., Go, E. P., Zhu, Z., & Desaire, H. (2016) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-016-1472-3 · Cited by 16
The use of mammalian two-hybrid technologies for high-throughput drug screening
Lievens, S., Caligiuri, M., Kley, N., & Tavernier, J. H. (2012) · Methods · doi:10.1016/j.ymeth.2012.08.003 · Cited by 15
The Distribution of Standard Deviations Applied to High Throughput Screening
Hanley, Q. S. (2019) · Scientific Reports · doi:10.1038/s41598-018-36722-4 · Cited by 14
Recent advances in functional assays of transcriptional enhancers
Babbitt, C. C., Markstein, M., & Gray, J. M. (2015) · Genomics · doi:10.1016/j.ygeno.2015.06.002 · Cited by 13
Extending the Detection Limit in Fragment Screening of Proteins Using Reverse Micelle Encapsulation
Fuglestad, B., Kerstetter, N. E., Bédard, S., & Wand, A. J. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00537 · Cited by 12
Recent advances in quantitative high throughput and high content data analysis
Moutsatsos, I. K., & Parker, C. N. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1154036 · Cited by 10
Advances in functional assays for high-throughput screening of ion channels targets
Trivedi, S., Liu, J., Liu, R., & Bostwick, R. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.513377 · Cited by 9
Target Engagement of Small Molecules: Thermal Profiling Approaches on Different Levels
Reckzeh, E. S., Brockmeyer, A., Metz, M., Waldmann, H., & Janning, P. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8891-4_4 · Cited by 9
Going Small: Using Biophysical Screening to Implement Fragment Based Drug Discovery
Bowling, J. J., Shadrick, W. R., Griffith, E. C., & Lee, R. E., Jr. (2016) · InTech eBooks · doi:10.5772/66423 · Cited by 6
Giannetti, A. M., Gilbert, H., Huddler, D. P., Reiter, M., Strande, C., Pitts, K. E., & Bravo, B. J. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620938-00019 · Cited by 5
Bulfer, S. L., Jean-Francois, F. L., & Arkin, M. R. (2016) · Methods and principles in medicinal chemistry · doi:10.1002/9783527683604.ch10 · Cited by 5
Self-citationCell-based assays in high-throughput mode (HTS)
Rajalingham, K. (2016) · Biotechnologia · doi:10.5114/bta.2016.62927 · Cited by 4
Computational Fragment-Based Drug Design
Sheng, C., Dong, G., & Wang, C. (2015) · Methods in pharmacology and toxicology · doi:10.1007/7653_2015_51 · Cited by 3
Cited by
Computational approaches streamlining drug discovery
Sadybekov, A. V., & Katritch, V. (2023) · Nature · doi:10.1038/s41586-023-05905-z · Cited by 1,279
DNA-Encoded Chemical Libraries: A Comprehensive Review with Succesful Stories and Future Challenges
Gironda-Martínez, A., Donckele, E. J., Samain, F., & Neri, D. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00118 · Cited by 344
Unleashing the power of generative AI in drug discovery
Gangwal, A., & Lavecchia, A. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103992 · Cited by 195
Organoids in image-based phenotypic chemical screens
Lukonin, I., Zinner, M., & Liberali, P. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00641-8 · Cited by 99
Bayesian optimization with known experimental and design constraints for chemistry applications
Hickman, R. J., Aldeghi, M., Häse, F., & Aspuru-Guzik, A. (2022) · Digital Discovery · doi:10.1039/d2dd00028h · Cited by 98
Metadata
- Authors
- Blay, V., Tolani, B., Ho, S. P., & Arkin, M. R.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 25
- Issue
- 10
- Pages
- 1807-1821
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W3048377477
- Cited by
- 387
- References
- 133
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.